chenodeoxycholic acid has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bergmann, F; Fortunato, F; Gonzalez, FJ; Hackert, T; Heger, U; Hinz, U; Huang, Z; Loos, M; Sun, H; Xu, Z; Zhang, Y | 1 |
Argent, BE; Carr, G; Gray, MA; Hasegawa, M; Hegyi, P; Ignáth, I; Inoue, M; Rakonczay, Z; Székely, CA; Takács, T; Venglovecz, V | 1 |
2 other study(ies) available for chenodeoxycholic acid and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
Farnesoid X receptor activation inhibits pancreatic carcinogenesis.
Topics: Animals; Bile Acids and Salts; Carcinogenesis; Carcinoma, Pancreatic Ductal; Cell Transformation, Neoplastic; Chenodeoxycholic Acid; Humans; Mice; Pancreas; Pancreatic Neoplasms | 2023 |
CFTR expression but not Cl- transport is involved in the stimulatory effect of bile acids on apical Cl-/HCO3- exchange activity in human pancreatic duct cells.
Topics: Animals; Bicarbonates; Biological Transport; Calcium; Calcium Signaling; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cells, Cultured; Chenodeoxycholic Acid; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Mutation; Pancreatic Ducts; Pancreatic Neoplasms; Transfection | 2009 |